Study to Compare Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Participants With Chronic Hepatitis B Infection Who Are Negative for Hepatitis B e Antigen

NCT01940341 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

426

Enrollment

INDUSTRY

Sponsor class

Conditions

HBeAg-negative Chronic Hepatitis B

Interventions

DRUG: TAF
DRUG: TDF
DRUG: TAF Placebo
DRUG: TDF Placebo

Sponsor

Gilead Sciences